Anna Sjögren

Hoofd Techniek/Wetenschap/O&O bij EGETIS THERAPEUTICS AB

56 jaar

Health Technology

Consumer Services

Actieve functies van Anna Sjögren

Bedrijven	Functie	Begin	Einde
EGETIS THERAPEUTICS AB	Hoofd Techniek/Wetenschap/O&O	-	-

Bedrijven	Functie	Begin	Einde
OxThera AB OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden.	Corporate Officer/Principal	01-01-2013	01-12-2017

University of Uppsala	Undergraduate Degree
Karolinska Institutet	Undergraduate Degree

Internationaal

Zweden

Operationeel

Undergraduate Degree	2
Chief Tech/Sci/R&D Officer	1
Corporate Officer/Principal	1

Sectoraal

Health Technology	3
Consumer Services	3

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	1
EGETIS THERAPEUTICS AB	Health Technology

Bedrijven in privébezit	1
OxThera AB OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden.	Health Technology

Bedrijven in privébezit

Health Technology